America Great Health (AAGH)
0.0029
0.00 (0.00%)
USD |
OTCM |
Jun 20, 16:00
America Great Health Revenue (Quarterly): 0.094M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.094M |
| December 31, 2023 | 0.0912M |
| September 30, 2023 | 0.0138M |
| June 30, 2023 | 0.0747M |
| March 31, 2023 | 0.0395M |
| December 31, 2022 | 0.0382M |
| September 30, 2022 | 0.0519M |
| June 30, 2022 | -0.0538M |
| March 31, 2022 | 0.0027M |
| December 31, 2021 | 0.1557M |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | 0.1955M |
| December 31, 2020 | |
| September 30, 2020 | 0.0001M |
| June 30, 2020 | 0.0055M |
| March 31, 2020 | |
| December 31, 2019 | |
| September 30, 2019 | |
| June 30, 2019 | |
| March 31, 2019 | |
| December 31, 2018 | |
| September 30, 2018 | |
| June 30, 2018 | |
| March 31, 2018 |
| Date | Value |
|---|---|
| December 31, 2017 | |
| September 30, 2017 | |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | |
| September 30, 2015 | 0.0739M |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | |
| September 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | |
| September 30, 2013 | 0.0447M |
| June 30, 2013 | 0.0066M |
| March 31, 2013 | |
| December 31, 2012 | |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | 0.0045M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-0.0538M
Minimum
Jun 2022
0.1955M
Maximum
Mar 2021
0.0545M
Average
0.0395M
Median
Mar 2023
Revenue (Quarterly) Benchmarks
| CEL-SCI Corp | -- |
| AIM ImmunoTech Inc | 0.04M |
| IGC Pharma Inc | 0.204M |
| NovaBay Pharmaceuticals Inc | 2.631M |
| Protalix BioTherapeutics Inc | 3.748M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -0.2266M |
| Total Expenses (Quarterly) | 0.2283M |
| Enterprise Value | 63.16M |
| Gross Profit Margin (Quarterly) | 87.32% |
| Profit Margin (Quarterly) | -240.9% |
| Earnings Yield | -1.41% |
| Normalized Earnings Yield | -1.414 |